BrainMapp Software Solutions has been established as a new spin‑off from the Autonomous University of Barcelona (UAB) and the Computer Vision Center (CVC) to bring to market a digital technology that assists medical teams during brain tumour surgeries by improving brain mapping and identifying critical zones.
Biolevate, a Paris‑based AI startup for life‑sciences, closed a €30 million Series A led jointly by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F and EQT Ventures. The funding will fuel product scaling, US expansion, and further AI integration in regulatory and drug‑development workflows.
The Competition Council approved Dr.Max’s purchase of 18 pharmacies from Marcos Provit (operating under the Evofarm brand) across several Romanian counties. The acquisition expands Dr.Max’s retail pharmacy footprint and was deemed not to significantly hinder competition.
Novadip Biosciences, a Belgian late‑stage biotech focused on regenerative bone therapies, raised €10.4 million in a convertible financing round led by New Science Ventures. The funds will support a pivotal Phase 3 trial of its autologous graft NVD003 and enable the company to draw on an €18 million EIB loan tranche, advancing regulatory filings and future commercial plans.
Aima Sense, a Swedish women’s health startup, reports losing millions due to social‑media censorship and has escalated the issue to the government. The company is now looking for investors and a strategic partner to fund its growth and become a global brand.
Aisla introduced “Ovunque vicini”, a free service that brings specialist care to ALS patients at home across Italy, using a 12‑hour‑a‑day operations centre and the Isa app to triage and connect patients with specialists from the NeMo clinical centers
London‑based startup Penelope Health raised €87 million in a funding round led by Thoreau, with participation from Bertelsmann Healthcare Investments, Twine Ventures and Seedcamp. The capital will be used to expand its real‑time payer policy intelligence platform, creating a shared infrastructure for payments and clinical rules, and to launch new products that reduce administrative burdens in healthcare. The company, founded in 2025, already covers policies for over 200 million Americans.
Amsterdam‑based MedTech startup Phosphoenix secured €1.3 million to advance its brain‑implant neuroprosthesis aimed at restoring functional vision for people with profound blindness, moving toward a first‑in‑human trial and a future Series A round.
Swedish sleep‑app startup Sleep Cycle announced a major cost‑cutting plan, slashing roughly 40% of its staff and ending multiple consulting engagements to save 35 million SEK. The move follows Altor becoming a major shareholder in the company.
Swedish startup Ordo Labs, focused on simplifying bureaucracy for pharmaceutical labs, was accepted into the prestigious Y Combinator accelerator after refining its pitch with support from a KTH team. The founders received positive feedback on the improvements needed.